Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone/Bupropion and Behavioral Weight Loss for Loss-of-Control Eating After Bariatric Surgery
NCT04599478Phase 3Completed
- Sponsor
- Yale University
- Start
- Jun 2021
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naltrexone, bupropion in obesity, sponsored by Yale University. Started Jun 2021; status: completed.
02
Drugs
naltrexonebupropion
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04599478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04599478.